Results 121 to 130 of about 1,254,090 (295)

Tumor Markers [PDF]

open access: yesClinical Chemistry, 2013
Md Sajal   +3 more
openaire   +2 more sources

Comparative Evaluation of Serum Markers in Prostate Disease and in Patients with Age - Related Risk

open access: yesThe International Journal of Biological Markers, 1993
A. Manna   +4 more
doaj   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

open access: yesMolecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

TPS cytosolic levels in non-malignant breast diseases

open access: yesThe International Journal of Biological Markers, 1995
A. Alvarez   +5 more
doaj   +1 more source

Field Effect Transistor Nanosensor for Breast Cancer Diagnostics [PDF]

open access: yes, 2012
Silicon nanochannel field effect transistor (FET) biosensors are one of the most promising technologies in the development of highly sensitive and label-free analyte detection for cancer diagnostics. With their exceptional electrical properties and small
Chen, Yu   +6 more
core  

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

open access: yesMolecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge   +17 more
wiley   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

open access: yesMolecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon   +4 more
wiley   +1 more source

Cytosolic Tissue-Type Plasminogen Activator (T-Pa) Levels in Breast Tumors and Hormone Dependence. Role of Ps2

open access: yesThe International Journal of Biological Markers, 1994
A. Ruibal   +5 more
doaj   +1 more source

RaMBat: Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects

open access: yesMolecular Oncology, EarlyView.
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley   +1 more source

CA125 Serum levels in tubercolosis patients

open access: yesThe International Journal of Biological Markers, 1995
J. Fernández B. De Quirós   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy